Compare KALV & SXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KALV | SXC |
|---|---|---|
| Founded | N/A | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Steel/Iron Ore |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 551.2M | 549.5M |
| IPO Year | N/A | N/A |
| Metric | KALV | SXC |
|---|---|---|
| Price | $16.12 | $7.91 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | ★ $30.00 | $10.00 |
| AVG Volume (30 Days) | ★ 1.3M | 994.6K |
| Earning Date | 03-11-2026 | 02-17-2026 |
| Dividend Yield | N/A | ★ 6.08% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.75 |
| Revenue | $1,426,000.00 | ★ $1,843,100,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $204.16 | $4.94 |
| P/E Ratio | ★ N/A | $10.54 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.74 | $6.24 |
| 52 Week High | $19.00 | $10.08 |
| Indicator | KALV | SXC |
|---|---|---|
| Relative Strength Index (RSI) | 54.89 | 53.70 |
| Support Level | $15.22 | $7.66 |
| Resistance Level | $16.16 | $8.16 |
| Average True Range (ATR) | 0.88 | 0.26 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 76.95 | 34.33 |
KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.
SunCoke Energy Inc operates as an independent producer of coke in the Americas. Its coke is primarily used as a principal raw material in the blast furnace steelmaking process as well as in the foundry production of casted iron. The company operates through three segments: Domestic Coke, Brazil Coke, and Logistics. It offers metallurgical and thermal coal. The company also provides handling and/or mixing services to steel, coke, electric utility, coal producing, and other manufacturing-based customers. The majority of revenue is derived from the Domestic Coke segment.